Treatment Of Ulcerative Colitis With Asacol Improved Patient Quality Of Life In As Early As Three Weeks, According To New Data Analysis

... Patients with ulcerative colitis (UC) treated with Asacol(R) (mesalamine) delayed-release tablets demonstrated a statistically significant improvement in overall quality of life in as early as three weeks according to a new data analysis by Procter & Gamble Pharmaceuticals, Inc., which provides quantified evidence to support a long-held assumption. [click link for full article] ...